Cite
HARVARD Citation
Smith, M. et al. (2021). Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial. European journal of cancer. pp. 138-146. [Online].